Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -121.55% is 28% below its 5-year average of -94.72%, near the low end of its 5-year range (-160.81%–-20.48%).
8.67% below its 12-month average of -111.85%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -124.15%.
EBITDA MARGIN
-121.55%
EBITDA MARGIN AVG TTM
-111.85%
EBITDA MARGIN AVG 3Y
-114.96%
EBITDA MARGIN AVG 5Y
-94.72%
EBITDA MARGIN AVG 10Y
-73.84%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.67%
CURRENT VS 3Y AVG
-5.73%
CURRENT VS 5Y AVG
-28.33%
CURRENT VS 10Y AVG
-64.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MaxCyte, Inc.
Market Cap
$113.55M
EBITDA Margin
-121.55%
TTM Avg
-111.85%
3Y Avg
-114.96%
5Y Avg
-94.72%
Market Cap
$113.02M
EBITDA Margin
-254.86%
TTM Avg
-347.69%
3Y Avg
-398.28%
5Y Avg
-4102.41%
Market Cap
$113.02M
EBITDA Margin
-699.90%
TTM Avg
-1930.94%
3Y Avg
-1689.05%
5Y Avg
-1903.35%
Market Cap
$111.61M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.57M
EBITDA Margin
-1036.29%
TTM Avg
-1034.54%
3Y Avg
-4587.22%
5Y Avg
-4766.38%
Market Cap
$110.12M
EBITDA Margin
-10.96%
TTM Avg
-24.45%
3Y Avg
-32.87%
5Y Avg
-38.11%
Market Cap
$116.14M
EBITDA Margin
-408000.00%
TTM Avg
-396456.25%
3Y Avg
-201636.71%
5Y Avg
-201636.71%
Market Cap
$116.04M
EBITDA Margin
-1187.82%
TTM Avg
-1407.84%
3Y Avg
-970.99%
5Y Avg
-809.42%
Market Cap
$116.47M
EBITDA Margin
-29.32%
TTM Avg
-13.32%
3Y Avg
-6.17%
5Y Avg
-1.07%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $113.55M | -121.55% | -111.85% | -114.96% | -94.72% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $113.02M | -254.86% | -347.69% | -398.28% | -4102.41% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $113.02M | -699.90% | -1930.94% | -1689.05% | -1903.35% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.61M | N/A | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.57M | -1036.29% | -1034.54% | -4587.22% | -4766.38% |
| Apyx Medical Corporation (APYX)vs › | $110.12M | -10.96% | -24.45% | -32.87% | -38.11% |
| Genelux Corporation (GNLX)vs › | $116.14M | -408000.00% | -396456.25% | -201636.71% | -201636.71% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.04M | -1187.82% | -1407.84% | -970.99% | -809.42% |
| BGM Group Ltd. (BGM)vs › | $116.47M | -29.32% | -13.32% | -6.17% | -1.07% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.95M | -475.96% | -475.96% | -272.89% | -272.89% |
Gross Margin
79.4%
EBITDA Margin
-121.5%
Operating Margin
-137.1%
Net Margin
-114.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -124.15% |
| 2026-03-31 | -53.24% |
| 2025-12-31 | -87.47% |
| 2025-09-30 | -142.39% |
| 2025-06-30 | -151.99% |
| 2025-03-31 | -106.04% |
| 2024-12-31 | -130.78% |
| 2024-09-30 | -159.08% |
| 2024-06-30 | -103.27% |
| 2024-03-31 | -97.41% |
| 2023-12-31 | -44.65% |
| 2023-09-30 | -160.81% |
| 2023-06-30 | -133.22% |
| 2023-03-31 | -142.44% |
| 2022-12-31 | -46.93% |
| 2022-09-30 | -65.48% |
| 2022-06-30 | -85.26% |
| 2022-03-31 | -31.69% |
| 2021-12-31 | -44.71% |
| 2021-09-30 | -20.48% |
| 2021-06-30 | -57.56% |
| 2021-03-31 | -93.26% |
| 2020-12-31 | -24.69% |
| 2020-09-30 | -37.74% |
| 2020-06-30 | -50.25% |
| 2020-03-31 | -48.18% |
| 2019-12-31 | -23.43% |
| 2019-09-30 | -23.43% |
| 2019-06-30 | -103.93% |
| 2019-03-31 | -103.93% |
| 2018-12-31 | -38.63% |
| 2018-09-30 | -38.63% |
| 2018-06-30 | -62.33% |
| 2018-03-31 | -62.33% |
| 2017-12-31 | -67.14% |
| 2017-09-30 | -67.14% |
| 2017-06-30 | -63.27% |
| 2017-03-31 | -63.27% |
| 2016-12-31 | -25.18% |
| 2016-09-30 | -25.18% |
| 2016-06-30 | -16.55% |
| 2016-03-31 | -16.55% |
| 2015-12-31 | -2.46% |
| 2015-09-30 | -2.46% |
| 2015-06-30 | -12.93% |
| 2015-03-31 | -12.93% |
| 2014-12-31 | -7.31% |
| 2014-09-30 | -7.31% |
| 2014-06-30 | -29.61% |
| 2014-03-31 | -29.61% |
